iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. (ITOS) is a publicly traded company in the Unknown sector. Across all available filings, 32 corporate insiders have executed 433 transactions totaling $298.9M, demonstrating a bearish sentiment with -$108.5M in net insider flow. The most recent transaction on Aug 29, 2025 involved a transaction of 46,300 shares valued at $0.
ITOS Insider Activity Summary
Who Is Buying ITOS Stock?
No significant insider buying has been recorded for ITOS in the recent period.
Who Is Selling ITOS Stock?
No significant insider selling has been recorded for ITOS in the recent period.
Is iTeos Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ITOS is bearish with an Insider Alignment Score of 32/100 and a net flow of -$108.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ITOS Frequently Asked Questions
Understanding ITOS Insider Activity
Insider trading at iTeos Therapeutics, Inc. (ITOS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 32 insiders are actively trading ITOS stock, having executed 433 transactions in the past 90 days. The most active insider is Aaron I. Davis (Executive), who has made 23 transactions totaling $78.6M.
Related Tools
Track iTeos Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ITOS file new Form 4 transactions